Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivus
Vivus
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sun, 11/11/12 - 09:21 am
Vivus
Orexigen
OraSure
This Week in Biotech: Part 2
Motley Fool
Sun, 11/11/12 - 09:19 am
Biocryst
Catalyst Pharmaceutical Partners
Pluristem Therapeutics
Vivus
Arena Pharmaceuticals
Eisai
Does VIVUS Need a Partner?
Motley Fool
Sat, 11/10/12 - 08:27 am
Vivus
Qsymia
weight loss
obesity
What Orexigen Is Saying -- and Not Saying
Motley Fool
Thu, 11/8/12 - 11:00 am
Orexigen
obesity
Contrave
Arena Pharmaceuticals
Vivus
Vivus Weight-Loss Drug Launch In Early Trouble
TheStreet.com
Tue, 11/6/12 - 12:30 pm
Vivus
Qsymia
Down 20%: What Is VIVUS' Market Opportunity?
Motley Fool
Tue, 11/6/12 - 12:21 pm
Vivus
obesity
Qsymia
Belviq
Arena Looks To Be The Clear Winner In The Weight Loss Space
Seeking Alpha
Sun, 11/4/12 - 10:27 am
Arena Pharmaceuticals
Vivus
Qsymia
weight loss
obesity
Belviq
Arena And Vivus To Announce Earnings On Same Day - What To Expect
Seeking Alpha
Fri, 11/2/12 - 11:11 am
Arena Pharmaceuticals
Vivus
earnings
Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch
Motley Fool
Thu, 11/1/12 - 06:09 pm
Arena Pharmaceuticals
obesity
Vivus
Belviq
Qsymia
The Wild October Ride Of Vivus
Seeking Alpha
Thu, 11/1/12 - 11:25 am
Vivus
obesity
Arena Pharmaceuticals
A Looming Threat for Arena and VIVUS
Motley Fool
Sun, 10/28/12 - 11:41 am
Arena Pharmaceuticals
Vivus
Orexigen
weight loss
obesity
Analysts Objectivity in Coverage of the Obesity Space
Motley Fool
Fri, 10/26/12 - 10:33 am
obesity
Arena Pharmaceuticals
Orexigen
Vivus
FDA Lightens Up on Obesity Drugs
Motley Fool
Mon, 10/22/12 - 06:12 pm
FDA
obesity
Contrave
Arena Pharmaceuticals
Vivus
Orexigen
What Does This Rejection Mean for Obesity Drugmakers?
Motley Fool
Sat, 10/20/12 - 10:36 am
Vivus
Qsymia
obesity
weight loss
Belviq
Arena Pharmaceuticals
Vivus Obesity Drug Fails to Win European Agency Backing
Bloomberg
Fri, 10/19/12 - 11:45 am
obsesity
Europe
Vivus
Qsiva
Qsymia
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 10/13/12 - 12:07 pm
Vivus
Affymax
NPS Pharmaceuticals
Is a VIVUS Buyout Still on the Table? And if So, by Whom?
Motley Fool
Fri, 10/12/12 - 11:02 am
Vivus
M&A
Bristol-Myers Squibb
Merck
JNJ
Arena Pharmaceuticals
Vivus Announces Suit Dismissal and 4 Healthcare Stocks in Demand
Wall Street Cheat Street
Sun, 10/7/12 - 11:41 am
Vivus
Arena Pharmaceuticals
Dendreon
Pfizer
Insmed
Vivus’s Weight-Loss Pill Covered by Insurers 30% of the Time
Bloomberg
Mon, 10/1/12 - 12:31 pm
Vivus
insurance
obesity
Qsymia
Insmed Ignites Higher and 4 Healthcare Stocks to Analyze Now
Wall Street Cheat Street
Sat, 09/29/12 - 12:08 pm
Insmed
Dendreon
Peregrine Pharmaceuticals
Vivus
Arena Pharmaceuticals
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »